SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 332 filers reported holding SEATTLE GENETICS INC in Q3 2018. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $41,018,000 | +231.3% | 241,397 | +124.9% | 0.06% | +100.0% |
Q1 2020 | $12,382,000 | -64.2% | 107,312 | -64.5% | 0.03% | -34.9% |
Q4 2019 | $34,549,000 | +123.1% | 302,372 | +66.8% | 0.04% | +79.2% |
Q3 2019 | $15,485,000 | +150.5% | 181,329 | +103.1% | 0.02% | +166.7% |
Q2 2019 | $6,181,000 | -68.9% | 89,299 | -67.1% | 0.01% | -70.0% |
Q1 2019 | $19,855,000 | +990.3% | 271,097 | +1048.1% | 0.03% | +1400.0% |
Q3 2018 | $1,821,000 | -91.7% | 23,612 | -94.4% | 0.00% | -93.1% |
Q1 2018 | $21,994,000 | +22.7% | 420,209 | +25.5% | 0.03% | +16.0% |
Q4 2017 | $17,918,000 | +395.1% | 334,921 | +403.4% | 0.02% | +400.0% |
Q3 2017 | $3,619,000 | -60.7% | 66,526 | -62.6% | 0.01% | -70.6% |
Q2 2017 | $9,214,000 | -81.1% | 178,091 | -77.1% | 0.02% | -80.9% |
Q1 2017 | $48,823,000 | +830.7% | 776,692 | +699.6% | 0.09% | +888.9% |
Q3 2016 | $5,246,000 | +1766.9% | 97,130 | +1295.7% | 0.01% | +800.0% |
Q2 2016 | $281,000 | -96.4% | 6,959 | -96.9% | 0.00% | -95.0% |
Q1 2016 | $7,863,000 | +99.3% | 224,089 | +154.9% | 0.02% | +150.0% |
Q4 2015 | $3,946,000 | -51.8% | 87,913 | -58.6% | 0.01% | -50.0% |
Q3 2015 | $8,193,000 | +447.7% | 212,484 | +587.6% | 0.02% | +433.3% |
Q2 2015 | $1,496,000 | -94.6% | 30,901 | -96.1% | 0.00% | -94.2% |
Q1 2015 | $27,778,000 | +8.0% | 785,805 | -1.8% | 0.05% | -3.7% |
Q4 2014 | $25,719,000 | +524.2% | 800,479 | +622.4% | 0.05% | +440.0% |
Q3 2014 | $4,120,000 | -19.2% | 110,806 | -16.8% | 0.01% | -28.6% |
Q2 2014 | $5,097,000 | +164.8% | 133,244 | +215.4% | 0.01% | +133.3% |
Q1 2014 | $1,925,000 | -74.3% | 42,248 | -77.5% | 0.01% | -75.0% |
Q4 2013 | $7,476,000 | +9.1% | 187,408 | +19.9% | 0.02% | +9.1% |
Q3 2013 | $6,853,000 | +32.7% | 156,350 | -4.7% | 0.02% | +37.5% |
Q2 2013 | $5,163,000 | – | 164,103 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |